India  

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

Video Credit: ANI - Duration: 01:43s - Published
COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

While commenting on World Health Organisation's decision to temporarily suspend clinical trials of hydroxychloroquine, Director General of Council of Scientific and Industrial Research (CSIR), Shekhar Mande supported ICMR's judgement on HCQ trials.

"I'm sure WHO will take consider the call in coming time.

We should trust ICMR's judgement, they are well qualified.

Hence, we should continue," said Shekhar Mande while talking to ANI.


You Might Like


Related videos from verified sources

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct [Video]

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early..

Credit: HT Digital Content     Duration: 03:14Published
WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG [Video]

WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early..

Credit: ANI     Duration: 01:36Published
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug [Video]

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe..

Credit: ANI     Duration: 01:26Published